Since the prevalence of NFkB mutations seems to be substantially higher in MMCLs compared to MM tumors, it seems possible that NFkB mutations often represent relatively late progression events, a conclusion that is supported by the heterogeneity of these mutations in some MM tumors [62]. Here, NFKB1 is linked to Miyoshi myopathy.